Aiming to illustrate an innovation model in an emerging market, this case summarizes the successful launch of drug-eluting stents at MicroPort and the development of innovation capabilities and culture within the company. The case also demonstrates a strategic dilemma appearing after one round of effective technological innovation and, more importantly, how understanding the value system — in this case, the health care system — is key to sustaining innovation.
|州||已出版 - 1 1月 2012|
Case normative numberGM-14-125-CE
Published byChina Europe International Business School
- Business model